Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Russell

Showing results (101-110 of 156) with videos related to

Pageof 16
Sort By:
Bone Marrow Transplantation|July 12, 2011
Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantationS W Bokhari, L Watson, S Nagra, et al.
Bone Marrow Transplantation|March 19, 2014
Acute disseminated encephalomyelitis following allo-SCT: central nervous system manifestation of GVHDC M Harvey, R Gottipati, S Schwarz, et al.
Bone Marrow Transplantation|October 3, 1998
Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxisJ L Byrne, C Stainer, H Hyde, et al.
British Journal of Haematology|February 26, 2000
Induction of remission after donor leucocyte infusion for the treatment of relapsed chronic idiopathic myelofibrosis following allogeneic transplantation: evidence for a 'graft vs. myelofibrosis' effectJ L Byrne, H Beshti, D Clark, et al.
British Journal of Haematology|September 1, 1981
Studies on the biochemical sequelae of therapy in Thy-acute lymphoblastic leukaemia with the adenosine deaminase inhibitor 2' deoxycoformycinN H Russell, H G Prentice, N Lee, et al.
Bone Marrow Transplantation|June 28, 2005
Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantationN H Russell, J L Byrne, R D Faulkner, et al.
British Journal of Haematology|December 19, 1998
A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical courseJ L Byrne, G I Carter, J M Davies, et al.
Blood|April 1, 1997
Allogeneic bone marrow transplant for multiple myelomaN H Russell, G Miflin, C Stainer, et al.
Bone Marrow Transplantation|May 7, 1999
Low incidence of human herpesvirus 8 in stem cell collections from myeloma patientsG M Cull, G I Carter, J M Timms, et al.
Blood|March 15, 1995
Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor)N Schmitz, P Dreger, M Suttorp, et al.
Pageof 16

Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
Bone Marrow Transplantation|July 12, 2011
Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantationS W Bokhari, L Watson, S Nagra, et al.
Bone Marrow Transplantation|March 19, 2014
Acute disseminated encephalomyelitis following allo-SCT: central nervous system manifestation of GVHDC M Harvey, R Gottipati, S Schwarz, et al.
Bone Marrow Transplantation|October 3, 1998
Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxisJ L Byrne, C Stainer, H Hyde, et al.
British Journal of Haematology|February 26, 2000
Induction of remission after donor leucocyte infusion for the treatment of relapsed chronic idiopathic myelofibrosis following allogeneic transplantation: evidence for a 'graft vs. myelofibrosis' effectJ L Byrne, H Beshti, D Clark, et al.
British Journal of Haematology|September 1, 1981
Studies on the biochemical sequelae of therapy in Thy-acute lymphoblastic leukaemia with the adenosine deaminase inhibitor 2' deoxycoformycinN H Russell, H G Prentice, N Lee, et al.
Bone Marrow Transplantation|June 28, 2005
Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantationN H Russell, J L Byrne, R D Faulkner, et al.
British Journal of Haematology|December 19, 1998
A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical courseJ L Byrne, G I Carter, J M Davies, et al.
Blood|April 1, 1997
Allogeneic bone marrow transplant for multiple myelomaN H Russell, G Miflin, C Stainer, et al.
Bone Marrow Transplantation|May 7, 1999
Low incidence of human herpesvirus 8 in stem cell collections from myeloma patientsG M Cull, G I Carter, J M Timms, et al.
Blood|March 15, 1995
Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor)N Schmitz, P Dreger, M Suttorp, et al.
Pageof 16